They running out of cash before year end means they need to raise more cash in the coming weeks .
The other point is that their lupus drug is not effective like the competitors . I think the Phase 3 results will be a disaster which will be the end of this Company .
We will see $2 and lower after dilution ..Markt my words
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.